Author(s):
Chiranjib Bisoi, Suman Acharyya, H.K Sundeep Kumar
Email(s):
gudlasaivyshnavi@gmail.com
DOI:
10.52711/0974-360X.2023.00453 
Address:
Chiranjib Bisoi1, Suman Acharyya2, H.K Sundeep Kumar3*
1M.Pharm Scholar, Institute of Pharmacy and Technology, Salipur, Cuttack, Odisha, India.
2Associate Professor, Netaji Subhas Chandra Bose Institute of Pharmacy, Tatla. Chakdaha, Nadia, 741222. West Bengal, India.
3Assistant Professor, Institute of Pharmacy and Technology, Salipur, Cuttack, Odisha, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 6,
Year - 2023
ABSTRACT:
The goal of this study was to create a sensitive and reliable UV-spectrophotometric and reverse phase liquid chromatographic method for determining Palbociclib in bulk and pharmaceutical dosage forms. The current UV approach uses methanol and phosphate buffer as a solvent to evaluate absorption at a maximum wavelength of 220nm. Waters Acquity BEH C18 (2.1 x 50mm, 1.7µm) UPLC column with Empower 2 was used in the UPLC procedure. The mobile phase was made up of 50:50 (v/v) methanol and phosphate buffer.The drug obeyed Beer Lambert's law in the UV technique in the concentration range of 1-70µg/ml with a regression coefficient of 0.999. The linearity level in the UPLC technique was 1-100µg/ml. In the validation investigation, the developed UV and UPLC procedures were successful. For the UPLC and UV methods, the percentage purity of the marketed dosage form of Palbociclib was found to be 98.76 percent and 98.84 percent, respectively. The percent RSD of all validation parameters investigated, as suggested by the ICH recommendations, was determined to be less than 2 in both techniques. The two methods established for determining Palbociclib in bulk and tablet doses were found to be accurate, simple, and validated.
Cite this article:
Chiranjib Bisoi, Suman Acharyya, H.K Sundeep Kumar. UV Spectrophotometric and UPLC assay methods for the determination of Palbociclib in bulk and Tablet Dosage Form. Research Journal of Pharmacy and Technology 2023; 16(6):2759-4. doi: 10.52711/0974-360X.2023.00453
Cite(Electronic):
Chiranjib Bisoi, Suman Acharyya, H.K Sundeep Kumar. UV Spectrophotometric and UPLC assay methods for the determination of Palbociclib in bulk and Tablet Dosage Form. Research Journal of Pharmacy and Technology 2023; 16(6):2759-4. doi: 10.52711/0974-360X.2023.00453 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-6-31
REFERENCES:
1 Cardoso F, Spence D, Mertz S, James D C, Sabelko K, Gralow J, et al. Global analysis of advanced/metastatic breast cancer: decade report (2005–2015) Breast. 2018, 39:131–138.https://doi.org/10.1016/j.breast.2018.03.002
2 Tripathy D, Im S A, Colleoni M, Franke F, Bardia A, Harbeck N, et al. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): A randomised phase 3 trial. Lancet Oncology. 2018, 19: 904–915.https://doi.org/10.1016/S1470-2045(18)30292-4
3 Beaver J A, Amiri-Kordestani L and Charlab R, FDA approval: palbociclib for the treatment of postmenopausal patients with estrogen receptor-positive, HER2-negative metastatic breast cancer. Clin Cancer Res. 2015, 12: 4760-4766. https://doi.org/10.1158/1078-0432.CCR-15-1185
4 Harper J W, Adams P D. Cyclin-dependent kinases. Chem Rev. 2001,101(8): 2511–26.https://doi.org/10.1021/cr0001030
5 Samson K, "LEE011 CDK Inhibitor Showing Early Promise in Drug-Resistant Cancers". Oncology Times. 2014, 36 (3):3940-3952. doi: 10.1097/01.COT.0000444043.33304.c1
6 Nalanda RB, Rao AS and Sankar DG: Determination of palbociclib in human plasma using high performance liquid chromatography - ultraviolet detection. Int J Pharm Sci and Res 2018; 9(9): 3883-88.https://dx.doi.org/10.5530/jyp.2022.14.16
7 K. Nithiyananthan, K.V.S Prasadarao. Analytical Method Development and Validation of Palbociclib in Its Pure Dosage Forms.J. Pharm, Biomed. A. Lett., 2020, 8(1): 26-29.
8 Yuvraj Dange, Somnath Bhingeand Vijay Salunkhe (2017): Optimization and Validation of RP-HPLC Method for Simultaneous Estimation of Palbociclib and Letrozole. Toxicology Mechanisms and Methodshttps://doi.org/10.1080/15376516.2017.1388458
9 Sreelakshmi .Ma, R. L. C. Sasidhara and Raviteja .Bb Simultaneous Estimation of Ribociclib and Palbociclib in Bulk Samples by Reverse Phase High Performance Liquid Chromatography International Journal of Pharmacy and Biological Sciences-IJPBSTM (2019) 9 (2): 413-421
10 PramadvaraKallepalli, MukthinuthalapatiMathrusri Annapurna, New stability-indicating liquid chromatographic method for determination of palbociclib (an anti-breast cancer drug), International Journal of Green Pharmacy. Jan-Mar 2018, 12 (1) | S270https://doi.org/10.22377/ijgp.v12i01.1632
11 Posocco B, Buzzo M, Poetto AS, Orleni M, Gagno S, Zanchetta M, et al. (2020) Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application. PLoS ONE 15(2): e0228822.https://doi.org/10.1371/journal.pone.0228822
12 Chavez AM, Rosing H, Hillebrand M, Tibben M, Alfred H. Schinkel, Beijnen JH. Development and validation of a bioanalytical method for the quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, and ribociclib in human and mouse matrices using liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry (2019) 411:5331–5345https://doi.org/10.1007/s00216-019-01932-w
13 Francisco Pena-Pereira, Isabel Costas-Mora, Vanesa Romero, Isela Lavilla, Carlos Bendicho, Advances in miniaturized UV-Vis spectrometric systems, TrAC Trends in Analytical Chemistry, 30(10) 2011. 1637-1648,https://doi.org/10.1016/j.trac.2011.04.018
14 Mondal P, Satla S, Raparla R, Quantification of Blonanserin in Human Plasma Using Liquid Chromatography- Electrospray Ionization-Tandem Mass Spectrophotometry-Application to Pharmacokinetic Study, J Young Pharm, 2016; 8(4): 406-414https://dx.doi.org/10.5530/jyp.2016.4.17